- Home
- CERS vs DOMO Comparison
CERS vs DOMO Comparison
Compare CERS & DOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERS
- DOMO
- Stock Information
- Founded
- CERS 1991
- DOMO 2010
- Country
- CERS United States
- DOMO United States
- Employees
- CERS N/A
- DOMO N/A
- Industry
- CERS EDP Services
- DOMO Computer Software: Prepackaged Software
- Sector
- CERS Technology
- DOMO Technology
- Exchange
- CERS Nasdaq
- DOMO Nasdaq
- Market Cap
- CERS 347.3M
- DOMO 324.2M
- IPO Year
- CERS 1997
- DOMO 2018
- Fundamental
- Price
- CERS $1.30
- DOMO $6.93
- Analyst Decision
- CERS Strong Buy
- DOMO Hold
- Analyst Count
- CERS 2
- DOMO 6
- Target Price
- CERS $3.50
- DOMO $10.25
- AVG Volume (30 Days)
- CERS 1.3M
- DOMO 442.3K
- Earning Date
- CERS 05-01-2025
- DOMO 05-22-2025
- Dividend Yield
- CERS N/A
- DOMO N/A
- EPS Growth
- CERS N/A
- DOMO N/A
- EPS
- CERS N/A
- DOMO N/A
- Revenue
- CERS $180,270,000.00
- DOMO $317,044,000.00
- Revenue This Year
- CERS $25.57
- DOMO $1.16
- Revenue Next Year
- CERS $10.54
- DOMO $1.87
- P/E Ratio
- CERS N/A
- DOMO N/A
- Revenue Growth
- CERS 15.29
- DOMO N/A
- 52 Week Low
- CERS $1.12
- DOMO $6.01
- 52 Week High
- CERS $2.54
- DOMO $10.15
- Technical
- Relative Strength Index (RSI)
- CERS 42.68
- DOMO 39.24
- Support Level
- CERS $1.12
- DOMO $7.76
- Resistance Level
- CERS $1.42
- DOMO $8.50
- Average True Range (ATR)
- CERS 0.11
- DOMO 0.62
- MACD
- CERS 0.01
- DOMO -0.06
- Stochastic Oscillator
- CERS 58.06
- DOMO 36.95
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
About DOMO Domo Inc. Class B
Domo Inc provides a cloud-based platform that digitally connects all the data, systems and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.